-
of the PhD project is to develop computational approaches to identify small molecule and peptide ligands that target therapeutically relevant receptors, with the vision to accelerate the drug discovery process
-
-specific drug responses, identifying transcriptional signatures indicative of treatment sensitivity, uncovering and mitigating paths to drug resistance, and predicting toxicity effects of drugs in healthy
-
integration, analysis, visualization, and data interpretation for patient stratification, discovery of biomarkers for disease risks, diagnostics, drug response assessment and monitoring of health. The precision
-
signatures indicative of treatment sensitivity, uncovering and mitigating paths to drug resistance, and predicting toxicity effects of drugs in healthy cells. In the dynamic research environment at SciLifeLab
-
covers data integration, analysis, visualization, and data interpretation for patient stratification, discovery of biomarkers for disease risks, diagnosis, drug response and monitoring of health
-
covers data integration, analysis, visualization, and data interpretation for patient stratification, discovery of biomarkers for disease risks, diagnosis, drug response and monitoring of health
-
encompasses data integration, analysis, visualization and data interpretation for patient stratification, discovery of biomarkers for disease risk, diagnosis, drug response and health monitoring. Research in
-
interpretation for patient stratification, discovery of biomarkers for disease risks, diagnosis, drug response and monitoring of health. The precision medicine research is expected to make use of existing strong
-
stratification, discovery of biomarkers for disease risks, diagnosis, drug response and monitoring of health. The precision medicine research is expected to make use of existing strong assets in Sweden and abroad